Pathophysiology of Ischemia Reperfusion Injury and Use of Fingolimod in Cardioprotection explores the physiology and pathophysiology of myocardial metabolism under normal and ischemic conditions. It examines current advancements and limitations of treatment, as well as prevention tactics that can be used against myocardial ischemia-reperfusion injury, also providing insights into potential new therapies. This concise, yet rigorous, coverage outlines an innovative cardioprotection strategy with insights into the mechanisms of myocardial ischemia-reperfusion injury and the role of fingolimod as a cardioprotective due to its anti-oxidant, anti-apoptotic and anti-inflammatory pathways.
Provides detailed and critical analysis of the latest research in the field, from molecular basis, to potential clinical relevance
Examines the effect of fingolimod/sphingosine 1-phosphate in cardioprotection, pointing to future myocardial preventative strategies
Presents full coverage of the mechanisms of ischemia reperfusion injury